Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Vet. Sci., 09 December 2025

Sec. Veterinary Clinical, Anatomical, and Comparative Pathology

Volume 12 - 2025 | https://doi.org/10.3389/fvets.2025.1656594

Case Report: Clinical and pathological features of a metastasizing malignant mixed epithelial and stromal tumor of the kidney in a Siberian tiger (Panthera tigris altaica)

Tanja &#x;vara
&#x;Tanja Švara1*Mitja Gomba
&#x;Mitja Gombač1Nika KojcNika Kojc2Mojca HarejMojca Harej3Marjan KastelicMarjan Kastelic3Peter KranPeter Kržan4Tamara Dolen&#x;ekTamara Dolenšek1Pavel KvapilPavel Kvapil3
  • 1Institute of Pathology, Wild Animals, Fish and Bees, Veterinary Faculty, University of Ljubljana, Ljubljana, Slovenia
  • 2Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
  • 3ZOO Ljubljana, Ljubljana, Slovenia
  • 4Graduate student of the Veterinary Faculty, University of Ljubljana, Ljubljana, Slovenia

We describe a case of mixed epithelial and stromal tumor (MEST) of the kidney with widespread metastases in an eight-year-old male Siberian tiger (Panthera tigris altaica) from the ZOO Ljubljana. The tiger presented with hematuria, and after unsuccessful treatment attempts with antibiotics, an ultrasound examination followed by laparotomy was performed. During the laparotomy, a large encapsulated lesion weighing 9.3 kg was found in the location of the left kidney and surgically removed. Histopathological examination of the lesion revealed an encapsulated tumor with a biphasic growth pattern consisting of mesenchymal and epithelial components. Numerous mitoses, hemorrhages, and necrosis were found in the mesenchymal component, which resembled ovarian stroma, leading to the diagnosis of malignant MEST of the kidney. After 3 months, the tiger clinically deteriorated and was euthanized after diagnostic imaging revealed multiple metastases. At necropsy, numerous metastases were found at the site of the previously excised tumor, at the laparotomy scar, in the peritoneum, liver, pancreas, omentum, mesentery, lungs, and sternal lymph nodes. Microscopically, the tumor lesions consisted only of the malignant mesenchymal component. To our knowledge, this is the first report of malignant MEST of the kidney with peritoneal seeding and distant metastases in animals.

1 Introduction

Tumors in captive tigers are uncommon. Mostly single cases of tumors such as pancreatic neuroendocrine tumor (1), Sertoli cell tumor (2), mesothelioma (3, 4), malignant peripheral nerve sheath tumor (5), meningioma (6), maxillary epithelial odontogenic tumor (7), pancreatic adenocarcinoma and Brunner’s gland adenoma (8), mandibular squamous cell carcinoma (9), Leydig cell tumor (10), cutaneous metastatic melanoma (11) and mammary carcinoma (12) have been reported to date. In addition, there are some retrospective studies on tumors in captive wild felids, which also report the occurrence of tumors in tigers (1317) with the most common being mammary adenocarcinomas (13, 15), uterine leiomyomas (14) and thyroid adenomas (14, 15).

Mixed epithelial and stromal tumor (MEST) of the kidney is a rare biphasic tumor consisting of epithelial and stromal components (18, 19). Due to its rarity and overlapping microscopic features, the tumor has been described under various names, such as adult mesoblastic nephroma, cystic hamartoma of the renal pelvis, leiomyomatous renal hamartoma, and more recently as renal epithelial and stromal tumor (REST) (20). According to data from human medicine, MEST are usually unilateral, confined to the kidney and renal pelvis (21) and occur predominantly in women (19, 22), typically during perimenopause (22). Microscopically, MEST show a biphasic growth pattern with cysts of different sizes and glands embedded in a spindle cell stroma that resembles ovarian stroma (22). Most MEST are benign tumors, but there are also rare cases with malignant transformation of the epithelial or stromal component (20, 2330) and aggressive clinical behavior (3034). Only a few cases have recurred (31, 32) or have either metastasized to the lymph nodes, liver and lungs or have metastasized systemically (22, 33, 35, 36).

To our knowledge, three reports of MEST have been published in veterinary medicine, in a ringtail lemur (Lemur catta) (37), a beagle dog (38) and a mouse (39). However, all cases exhibited benign clinicopathologic features and had not metastasized.

The aim of our study is to describe a case of malignant MEST in a Siberian tiger (Panthera tigris altaica) with very aggressive clinical behavior with peritoneal seeding and distant metastases that led to euthanasia 3 months after initial diagnosis based on excisional biopsy. We report the history, gross and histopathologic findings of the excisional biopsy, imaging results, and necropsy findings.

2 Case description

An eight-year-old intact male Siberian tiger (Panthera tigris altaica) weighing 180 kg from the ZOO Ljubljana was presented with hematuria. The animal showed no other clinical signs of disease and did not respond to initial antibiotic treatment for suspected urinary bladder infection. As the animal was not trained for voluntary ultrasound examination, it was performed under general anesthesia. During the examination, an abdominal mass was detected on ultrasonography, which warranted an immediate laparotomy during the same general anesthesia. Anesthesia was induced with 300 mg ketamine (Ketamidor 100 mg/mL, VetViva Richter GmbH, Austria), 15 mg midazolam (Midazolam Accord 5 mg/mL, Accord Healthcare, Poland), 10 mg butorphanol (Butomidor 10 mg/mL, VetViva Richter GmbH, Austria), and 8 mg medetomidine (Domitor 1 mg/mL, Orion Corporation, Finland), administered intramuscularly. The dosage of the drugs was based on standard species-specific protocols. Following induction of anesthesia, an intravenous catheter was placed and the tiger was intubated with an endotracheal tube. Despite apparent sedation, a positive palpebral reflex was noted, indicating insufficient anesthetic depth. Therefore, an additional bolus of ketamine was administered intravenously to deepen anesthesia. Anesthesia was maintained with isoflurane administered via anesthetic circuit. Before extubation, reversal agents were administered subcutaneously: atipamezole (Antisedan 5 mg/mL, Orion Corporation, Finland) to antagonize the effect of medetomidine, and flumazenil (Anexate 100 μg/mL, Cheplapharm Arzneimittel GmbH, Germany) to reverse the effect of midazolam. The laparotomy revealed a very large encapsulated lesion at the location of the left kidney, which was then surgically removed. During the same procedure, after inspection of the abdominal cavity, a splenectomy was performed due to a nodule on the spleen. No other lesions suggestive of metastases were found in the abdominal cavity and thoracic radiographs were unremarkable. The tiger made a full recovery, and hematologic and biochemical parameters were within normal limits on the day of surgery.

The entire encapsulated lesion and spleen were immediately chilled and submitted to the Institute of Pathology, Wild Animals, Fish and Bees, of the Veterinary Faculty University of Ljubljana.

The lesion from the location of the left kidney measured 35 × 26 × 12 cm, weighed 9.3 kg, and was well circumscribed by a gray-white, 5-mm-thick capsule. After partial removal of the capsule, the lesion’s surface was gray-red, lobulated, and had both solid areas with an arboriform architecture and cystic areas (Figure 1). The cut surface of the lesion was gray-red, solid, cystic and bosselated with numerous hemorrhages and necrotic areas. The spleen had a well-demarcated, exophytic, nodular, gray-red lesion measuring 2 × 1.8 × 1.4 cm with a red cut surface.

Figure 1
Close-up of a cross-section of a lung with severe lesions. The tissue appears red and mottled with areas of necrosis, hemorrhage, and nodular formations. Blue arrows indicate specific regions of interest.

Figure 1. The excisional biopsy of the lesion in the left kidney of a Siberian tiger (Panthera tigris altaica), diagnosed with malignant mixed epithelial and stromal tumor (MEST). The well-circumscribed tumor was encapsulated by a grey-white capsule (blue arrows). The surface of the tumor after partial removal of the capsule was grey-red, lobulated and with solid and cystic areas. The solid areas displayed an arboriform architecture. Bar = 5 cm.

Representative samples of both lesions were fixed in 10% neutral buffered formalin, routinely processed for microscopic examination, sectioned at 4 μm and stained with hematoxylin and eosin (H&E) and examined under a light microscope. Immunohistochemistry was performed according to the manufacturer’s instructions to confirm the origin of the neoplastic cells and to investigate a possible hormonal influence on tumor pathogenesis. The procedure was performed on selected 4-μm-thick paraffin sections. Details of the utilized primary antibodies and immunohistochemistry protocols used are provided in Table 1.

Table 1
www.frontiersin.org

Table 1. Details of the primary antibodies and immunohistochemical protocols.

Microscopic examination of the lesion from the location of the left kidney revealed a multinodular tumor composed of epithelial and stromal components, the majority of which was well demarcated from the renal parenchyma by a fibrous capsule.

The epithelial component displayed tubular and cystic structures lined by cuboidal to columnar neoplastic epithelial cells resembling urothelium with umbrella cells, with the cystic spaces containing serous or proteinaceous fluid (Figures 2A,B). The neoplastic epithelial cells exhibited mild anisocytosis, had a small to moderate amount of pale eosinophilic cytoplasm, round to oval nuclei exhibiting moderate anisokaryosis, and a single prominent nucleolus or an inconspicuous nucleolus. Mitoses were rare, with 1 or less than 1 mitosis per 10 highpower field (2.37 mm2). The tubular structures exhibited positive immunolabeling for CKAE1/AE3, GATA3 and PAX8, while the stromal component was negative (Figure 3). Despite multiple attempts to optimize the protocol, no specific immunolabeling for estrogen and progesterone receptors, calretinin, CD20, p63, CD31, CD34 and uroplakin III was detected in either the tumor or the positive controls.

Figure 2
Histological images labeled A through D. Panel A shows a low magnification view of tissue with glandular structures. Panel B displays a papillary configuration of cells. Panel C presents a section with a well-defined lesion. Panel D is a high magnification of densely packed cells with visible nuclei.

Figure 2. Microscopic findings of malignant mixed epithelial and stromal tumor (MEST) in the left kidney of a Siberian tiger (Panthera tigris altaica). The tumor was composed of epithelial and stromal components. (A,B) The epithelial component displayed papillary, tubular and cystic structures lined by epithelial cells. H&E, bar = 1,000 μm. (C) Focus of densely packed pleomorphic spindle stromal cells. H&E, bar = 1,000 μm. (D) High mitotic activity and atypical mitoses in the spindle stromal cells. H&E, bar = 50 μm.

Figure 3
Two histology images show different staining results. The top image is labeled CKAE1/AE3, displaying dense, dark brown staining along tissue structures. The bottom image, labeled GATA3, exhibits lighter brown, more scattered staining, indicating varied expression in different cell types. Both utilize blue counterstaining to highlight nuclei.

Figure 3. Microscopic findings of malignant mixed epithelial and stromal tumor (MEST) in the left kidney of a Siberian tiger (Panthera tigris altaica). Epithelial cells lining tubular structures were immunolabeled for GATA3 and CK AE1/AE3, while the stromal component showed immunolabeling for vimentin and αSMA. Immunohistochemistry, bar = 100 μm.

The stromal component consisted predominantly of neoplastic spindle cells reminiscent of ovarian stroma and multifocal groups of polygonal to round neoplastic stromal cells. The neoplastic spindle cells formed interwoven bundles and were multifocally condensed around neoplastic epithelial structures and blood vessels. In addition, multifocal papillary-like structures of neoplastic spindle cells were observed protruding into the lumina of the cystic structures and covered by neoplastic epithelial cells. The stromal cells exhibited moderate anisocytosis, with small to moderate amounts of eosinophilic cytoplasm. The nuclei exhibited moderate anisokaryosis, were large, oval to round with coarse chromatin, prominent nucleoli and frequent mitotic figures, 90 per 10 high-power fields (2.37 mm2), including atypical mitoses (Figures 2C,D). This component also demonstrated extensive necrosis and hemorrhage, with expansile rather than infiltrative tumor growth toward the surrounding renal tissue. Invasion of blood and lymphatic vessels was not observed. Stromal component expressed diffuse positive immunolabeling for CD10, vimentin, and desmin, and focal imunolabeling for alpha smooth muscle actin (αSMA), consistent with smooth muscle differentiation. Immunohistochemical stains for Melan-A, HMB-45, carbonic anhydrase IX (CAIX) and von Willebrand factor/factor VIII complex (FVIII) were negative in both the epithelial and stromal components. Interstitial fibrosis and tubular atrophy were observed in the remaining renal parenchyma.

Based on the gross, microscopic and immunohistochemical features of the tumor, a malignant MEST of the kidney was diagnosed. The nodular lesion in the spleen was diagnosed as hematoma.

After 3 months, the tiger clinically deteriorated. He developed lethargy and cachexia, with marked weight loss and muscle wasting despite normal food intake. Radiographic and ultrasound imaging revealed multiple metastases in the lungs and abdominal cavity. Based on the poor prognosis and in accordance with ethical and welfare considerations, the tiger was euthanized ad tabulam using 40 mL of T-61 (1 mL/ 5 kg) (1 mL containing embutramide 200 mg, mebezonium iodide 50 mg, and tetracaine hydrochloride 5 mg; Intervet International BV, Boxmeer, Netherlands) administered intravenously after it had already been under general anesthesia (combination of medetomidine (40 mcg/kg), ketamine, butorphanol and midazolam 0.1 mg/ kg) for follow-up diagnostic procedures, and immediately submitted for necropsy.

At necropsy, numerous tumors of various sizes were found at the site of the previously excised tumor of the left kidney, in the area of the laparotomy scar, in the parietal peritoneum, in the serosa of the stomach and urinary bladder, in the liver, pancreas, omentum and mesentery (Figure 4). The tumor at the site of the previously excised renal tumor was the largest and measured 25 × 17 × 16 cm, the tumor in the area of the laparotomy scar measured 18 × 9 × 3 cm, while the tumors in the parenchymal organs, the omentum and the mesentery measured up to 9 × 2.5 × 2 cm. The tumors were round to oval, multinodular, gray-red, smooth, poorly demarcated and firm, with red-gray, smooth, bosselated cut surfaces. These tumors and the finding of two liters of watery, slightly opaque fluid in the abdominal cavity were consistent with peritoneal seeding. Numerous tumors ranging in size from 2 mm to 10 × 6 × 6 cm, grossly resembling the tumors in the abdominal cavity, were also scattered throughout the lung lobes. The sternal lymph nodes were severely enlarged and measured up to 8 × 4 × 4 cm. The tiger was in poor body condition. Moderate eccentric hypertrophy of the left ventricle with mild epicardial fibrosis, moderate endocardial fibrosis and severe dilatation of the right ventricle were also noted. In addition, there was 0.5 liters of yellow serous fluid in the thoracic cavity.

Figure 4
Surgical view of animal tissue, with a large, irregularly shaped mass of varying colors and textures. Surrounding organs and tissues are visible, including intestines. Arrowheads and arrows mark specific areas.

Figure 4. Necropsy findings in a Siberian tiger (Panthera tigris altaica) with malignant mixed epithelial and stromal tumor (MEST). Abdominal cavity with widespread peritoneal seeding. Tumors of different sizes are scattered in the abdominal cavity at the site of the previously excised tumor (blue arrow) and in the omentum. Arrowheads indicate the costal arch.

Samples of tumors from all the above listed organs and sites as well as samples from the right kidney, intestine, adrenal glands, mesenteric lymph nodes, heart, and brain were fixed in 10% buffered formalin, routinely embedded in paraffin, sectioned at 4 μm, stained with H&E, and examined under a light microscope. Microscopically, the tumors were poorly demarcated, nonencapsulated, infiltrative, densely cellular, and consisted exclusively of a malignant mesenchymal (stromal) component that resembled the stromal component of the primary tumor of the left kidney. The mitoses were numerous and often atypical. Numerous necroses and hemorrhages were scattered throughout the tumors.

The case was diagnosed as malignant MEST of the left kidney with widespread peritoneal seeding and distant metastases of the mesenchymal (stromal) component of the tumor to the lungs and sternal lymph nodes.

3 Discussion

MEST are rare in humans and account for 0.2% of all renal tumors (30). Most MEST are benign, but in very rare cases malignant transformation occurs (2330, 40) and aggressive clinical behavior has been described (3034). MEST with benign histopathologic features but extension into the inferior vena cava has also been described (41).

The gross, microscopic and immunohistochemical features of the tumor described in this tiger closely resemble those described in other cases of malignant MEST in humans (20, 2330, 34). The epithelial component showed positive imunolabeling for cytokeratins and GATA3, while expression of vimentin, αSMA, and desmin confirmed smooth muscle differentiation within the stromal component. Given the biphasic architecture, morphological features, and aggressive biological behavior, several malignant biphasic renal tumors were considered in the differential diagnosis. These included papillary renal cell carcinoma with prominent spindle cell stroma, sarcomatoid renal cell carcinoma, and synovial sarcoma. Additional biphasic neoplasms, such as mesothelioma, epithelioid hemangiosarcoma, and urothelial carcinoma, were also included in the differential based on tumor architecture and anatomic location.

Correlation of histopathological and immunohistochemical findings enabled exclusion of these differential diagnoses. The presence of a well-defined mesenchymal component lined by an epithelial component ruled out papillary renal cell carcinoma with spindle cell stroma. Renal cell carcinoma, including sarcomatoid variants, was excluded by the absence of CAIX expression. Epithelioid hemangiosarcoma was excluded by negative immunostaining for FVIII.

In malignant MEST in humans, malignant transformation can occur in either the epithelial or stromal component (20, 2330), but most commonly malignant MEST has a malignant sarcomatous (stromal) component (25, 26, 29, 31, 32, 34), which is similar to our case. The malignant component in the herein described MEST resembled monophasic undifferentiated synovial sarcoma (23), synovial sarcoma (32), sarcoma with rhabdoid differentiation (24), rhabdomyosarcoma and chondrosarcoma (25), carcinosarcoma (36), undifferentiated sarcoma (26) and papillary renal cell carcinoma (28, 34). Sarcomas and carcinosarcomas typically lack expression of epithelial markers by immunohistochemistry. In contrast, the diffuse and strong immunolabeling for CK AE1/AE3 observed in the epithelial component is characteristic of MEST and differs from synovial sarcoma, in which cytokeratin expression is usually patchy, weak, and irregularly distributed among tumor cells (23, 25, 31, 32). PAX8, the tissue-specific transcription factors expressed primarily in the renal and Mullerian systems and also in Wolffian duct structures, has also been reported in MEST (20, 28, 41). Furthermore, coexpression of CD10 (20, 25, 36, 40), desmin (23, 36, 40), and αSMA (20, 23, 31, 40) in the stromal component provides additional support for the diagnosis of MEST.

In animals, MEST are even rarer than in humans. To the authors’ knowledge, only three cases have been described in animals, specifically in a 14.5-year-old female ringtail lemur, a 22 month-old female beagle dog, and a 32-week-old female mouse, all of which had only benign pathomorphologic features (3739). All three cases reported in animals were diagnosed in females (3739) and were considered young (38) or middle-aged (37, 39).

Despite the gross and microscopic similarities of the tumor diagnosed in the tiger, the case differs from human MEST in many other features.

Most human MEST are diagnosed in women (29, 34), with a female to male ratio of 6:1 to 10:1, in perimenopause and at an average age of about 45 years (19, 42). Some studies describing long-term oral estrogen therapy and immunopositivity for estrogen and progesterone receptors suggest a possible role of hormonal stimulation in the pathogenesis of MEST (4244). Only a few cases of MEST have been described in male patients (26, 27, 40, 45, 46). The age of men with MEST is variable; according to some data, patients were older, with an average age of 71 years (47), while other cases of MEST were diagnosed in forty-year-olds (45, 46) or even in 19-year-old men with no history of hormone therapy (27). In some cases, a history of hormone therapy for prostate cancer has been described, which may have an impact on tumor progression (26).

The tiger was an eight-year-old intact male, which given the species’ average lifespan of 15 to.

20 years, corresponds to middle age (48). It was not under hormone therapy. Despite multiple attempts to optimize the protocol, immunolabeling of the tumor for estrogen and progesterone receptors was unsuccessful, thereby precluding assessment of their expression in the tumor. Due to the unsuccessful receptor immunolabeling, the involvement of hormonal mechanisms in the pathogenesis of the tumor cannot be confirmed, although this seems unlikely. The most common symptoms in human patients with MEST of the kidney are hematuria, flank pain, a palpable mass, or a urinary tract infection. Approximately 25% of cases of MEST are diagnosed incidentally (43, 44). In animals, the ringtail lemur with MEST showed reduced appetite and weight loss, and abdominal mass was palpated and visualized radiographically (37), while MEST in the dog and mouse were diagnosed incidentally at necropsy after the animals were euthanized for experimental studies (38, 39). The only clinical sign observed in the tiger prior to excisional biopsy and diagnosis of MEST of the kidney was hematuria that did not respond to antibiotic therapy.

The prognosis for MEST is generally good, while the prognosis for malignant MEST varies from case to case - some people are free of metastases or recurrence after nephrectomy, while some tumors have an aggressive clinical course with recurrence (27, 31, 32) or metastasize to the lymph nodes (22), liver (35) or lungs (33) or develop systemic metastases (36) and lead to death (26, 31, 32, 36). The shortest time from diagnosis to death was 5 months despite chemotherapy and radiotherapy (46). In our case, disease progression was also very rapid, with only 3 months from diagnosis to euthanasia due to widespread peritoneal seeding and metastases in the lungs and sternal lymph nodes. Complete resection with clean surgical margins is important for a good outcome in patients with malignant and benign MEST. Positive surgical margins, tumor disruption or tumor spillage during surgery may be associated with a poor outcome (32, 34, 46). Peritoneal seeding of benign MEST has been described after incomplete resection (48). Given the widespread peritoneal seeding and a large tumor in the abdominal wall at the laparotomy scar, we believe that the rapid progression of disease was probably the result of intraoperative tumor spillage and that the extreme size of the tumor probably contributed greatly to this outcome.

4 Conclusion

This is the first described case of malignant MEST of the kidney with peritoneal seeding and distant metastases in a Siberian tiger (Panthera tigris altaica) and the first such case ever reported in an animal. Although all previously reported MEST in animals have been benign and most MEST described in humans are also benign, the tumor described here showed microscopic features of malignant transformation with numerous and atypical mitoses, hemorrhages and necrosis on excisional biopsy. After only 3 months, the tiger was euthanized as its health had deteriorated considerably. This was the result of tumors at the site of the previously excised kidney tumor and laparotomy scar, peritoneal seeding, and metastases in the lungs and sternal lymph nodes, which microscopically consisted of the malignant component of the previously removed MEST of the kidney. This indicates that extreme caution is required when surgically removing these tumors, as intraoperative tumor spillage may lead to peritoneal seeding and distant metastases within a short period of time.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

Ethical approval was not required for the study involving animals in accordance with the local legislation and institutional requirements because the approval of the Ethics Committee/Welfare Authority was not required as all samples were taken intraoperatively or during necropsy. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.

Author contributions

TŠ: Visualization, Data curation, Conceptualization, Writing – original draft, Writing – review & editing, Investigation. MG: Writing – review & editing, Investigation, Writing – original draft, Data curation, Visualization, Conceptualization. NK: Investigation, Writing – original draft, Visualization. MH: Investigation, Writing – review & editing, Data curation. MK: Investigation, Data curation, Writing – review & editing. PKr: Investigation, Data curation, Writing – review & editing. TD: Data curation, Investigation, Writing – review & editing. PKv: Investigation, Writing – review & editing, Supervision, Writing – original draft, Data curation.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by the Slovenian Research and Innovation Agency through research core funding P4-0092 (Animal Health, Environment, and Food Safety) and P3-0054 (Pathology and Molecular Genetics).

Acknowledgments

The authors would like to thank the Slovenian Research and Innovation Agency for supporting the research.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Gen AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Nyska, A, Goldstein, J, and Klein, B. Immunohistochemical study of pancreatic neuroendocrine tumor in Panthera tigris tigris. J Wildl Dis. (1996) 32:541–4. doi: 10.7589/0090-3558-32.3.541,

PubMed Abstract | Crossref Full Text | Google Scholar

2. Scudamore, CL, and Meredith, AL. Sertoli cell tumour in an Amur tiger. J Comp Pathol. (2001) 124:79–82. doi: 10.1053/jcpa.2000.0422,

PubMed Abstract | Crossref Full Text | Google Scholar

3. Wiedner, EB, Isaza, R, Lindsay, WA, Case, AL, Decker, J, and Roberts, J. Pericardial mesothelioma in a Bengal tiger (Panthera tigris). J Zoo Wildl Med. (2008) 39:121–3. doi: 10.1638/2007-0080.1,

PubMed Abstract | Crossref Full Text | Google Scholar

4. Coe, SE, Garner, MM, and Kiupel, M. Immunohistochemical characterization of mesothelioma in 6 large felids. J Vet Diagn Invest. (2021) 33:767–71. doi: 10.1177/10406387211015640,

PubMed Abstract | Crossref Full Text | Google Scholar

5. Steinmetz, HW, Rütten, M, Ruess-Melzer, K, Ohlerth, S, Lischer, C, Oevermann, A, et al. Clinical course of a malignant peripheral nerve sheath tumor in a Siberian tiger (Panthera tigris altaica). J Vet Diagn Invest. (2010) 22:970–5. doi: 10.1177/104063871002200621,

PubMed Abstract | Crossref Full Text | Google Scholar

6. Akin, EY, Baumgartner, WA, Lee, JK, and Beasley, MJ. Meningioma in a Bengal tiger (Panthera tigris tigris). J Zoo Wildl Med. (2013) 44:761–4. doi: 10.1638/2012-0215R.1,

PubMed Abstract | Crossref Full Text | Google Scholar

7. Fecchio, RS, Gomes, M d S, Xavier, JG, Kunze, PE, and Gioso, MA. Maxillary calcifying epithelial odontogenic tumor in a Siberian tiger (Panthera tigris altaica). J Vet Dent. (2015) 32:120–1. doi: 10.1177/089875641503200206

Crossref Full Text | Google Scholar

8. Gombač, M, Dolenšek, T, Jaušovec, D, Kvapil, P, Švara, T, and Pogačnik, M. Simultaneous occurrence of pancreatic adenocarcinoma and Brunner’s gland adenoma in a Siberian tiger (Panthera tigris altaica). J Comp Pathol. (2015) 153:363–7. doi: 10.1016/j.jcpa.2015.08.008,

PubMed Abstract | Crossref Full Text | Google Scholar

9. de Oliveira, AR, de Carvalho, TF, Arenales, A, Tinoco, HP, Coelho, CM, Costa, M, et al. Mandibular squamous cell carcinoma in a captive Siberian tiger (Panthera tigris altaica). Braz J Vet Pathol. (2018) 11:97–101. doi: 10.24070/bjvp.1983-0246.v11i3p97-101

Crossref Full Text | Google Scholar

10. Kawata, R, Tatsuhito, I, Hori, T, Machida, Y, Ochiai, K, Azakami, D, et al. Leydig cell tumor in an Amur tiger (Panthera tigris altaica). J Vet Med Sci. (2019) 81:186–9. doi: 10.1292/jvms.18-0573

Crossref Full Text | Google Scholar

11. Eckstein, C, Tinoco, HP, Coelho, CM, Lima, PA, Rocha, CEV, and Santos, RL. Cutaneous metastatic melanoma in a Siberian tiger (Panthera tigris altaica) – case report. Arq Bras Med Vet Zootec. (2020) 72:921–5. doi: 10.1590/1678-4162-10319

Crossref Full Text | Google Scholar

12. Fraser, C, Keong Kok, M, Shameha Abdul Razak, I, Puspitasari, Y, and Salleh, A. Diagnostic challenge in veterinary pathology: metastatic mammary tumor in a female tiger (Panthera tigris). Vet Pathol. (2024) 61:508–11. doi: 10.1177/03009858241226650,

PubMed Abstract | Crossref Full Text | Google Scholar

13. Owston, MA, Ramsay, EC, and Rotstein, DS. Neoplasia in felids at the Knoxville zoological gardens, 1979–2003. J Zoo Wildl Med. (2008) 39:608–13. doi: 10.1638/2008-068.1,

PubMed Abstract | Crossref Full Text | Google Scholar

14. Junginger, J, Hansmann, F, Herder, V, Lehmbecker, A, Peters, M, Beyerbach, M, et al. Pathology in captive wild felids at German zoological gardens. PLoS One. (2015) 10:e0130573. doi: 10.1371/journal.pone.0130573,

PubMed Abstract | Crossref Full Text | Google Scholar

15. Kloft, HM, Ramsay, EC, and Sula, MM. Neoplasia in captive Panthera species. J Comp Pathol. (2019) 166:35–44. doi: 10.1016/j.jcpa.2018.10.178,

PubMed Abstract | Crossref Full Text | Google Scholar

16. Mathieu, A, and Garner, MM. A retrospective study of neoplasia in nondomestic felids in human care, with a comparative literature review. J Zoo Wildl Med. (2021) 52:413–26. doi: 10.1638/2020-0077,

PubMed Abstract | Crossref Full Text | Google Scholar

17. d’Aquino, I, Piegari, G, Casciaro, SM, Prisco, F, Rosato, G, Silvestre, P, et al. An overview of neoplasia in captive wild felids in southern Italy zoos. Front Vet Sci. (2022) 9:899481. doi: 10.3389/fvets.2022.899481

Crossref Full Text | Google Scholar

18. Michal, M, and Syrucek, M. Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract. (1998) 194:445–8. doi: 10.1016/S0344-0338(98)80038-1,

PubMed Abstract | Crossref Full Text | Google Scholar

19. Michal, M. Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract. (2000) 196:275–6. doi: 10.1016/S0344-0338(00)80078-3,

PubMed Abstract | Crossref Full Text | Google Scholar

20. Tinguria, M, and Chorneyko, K. Mixed epithelial and stromal tumor: a rare renal neoplasm—case report with clinicopathologic features and review of the literature. Case Rep Pathol. (2023) 2023:1–11. doi: 10.1155/2023/3528377,

PubMed Abstract | Crossref Full Text | Google Scholar

21. Cruz Bendezú, AM, Batter, TH, and Mufarrij, P. Mixed epithelial and stromal tumor of the kidney extending to the proximal ureter in a 41-year-old female. Urol Case Rep. (2021) 38:1731. doi: 10.1016/j.eucr.2021.101731,

PubMed Abstract | Crossref Full Text | Google Scholar

22. Holkar, PS, Jain, T, Kavishwar, V, and Pandya, JS. Metastasis in mixed epithelial stromal tumour of the kidney: a rare presentation. BMJ Case Rep. (2019) 12:293. doi: 10.1136/bcr-2019-229293,

PubMed Abstract | Crossref Full Text | Google Scholar

23. Svec, A, Hes, O, Michal, M, and Zachoval, R. Malignant mixed epithelial and stromal tumor of the kidney. Virchows Arch. (2001) 439:700–2. doi: 10.1007/s004280100518,

PubMed Abstract | Crossref Full Text | Google Scholar

24. Sukov, WR, Cheville, JC, Lager, DJ, Lewin, JR, Sebo, TJ, and Lewin, M. Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumors. Hum Pathol. (2007) 38:1432–7. doi: 10.1016/j.humpath.2007.03.022,

PubMed Abstract | Crossref Full Text | Google Scholar

25. Jung, SJ, Shen, SS, Tran, T, Jun, SY, Truong, L, Ayala, AG, et al. Mixed epithelial and stromal tumor of kidney with malignant transformation: report of two cases and review of literature. Hum Pathol. (2008) 39:463–8. doi: 10.1016/j.humpath.2007.08.008,

PubMed Abstract | Crossref Full Text | Google Scholar

26. Suzuki, T, Hiragata, S, Hosaka, K, Oyama, T, Kuroda, N, Hes, O, et al. Malignant mixed epithelial and stromal tumor of the kidney: report of the first male case. Int J Urol. (2013) 20:448–50. doi: 10.1111/j.1442-2042.2012.03155.x,

PubMed Abstract | Crossref Full Text | Google Scholar

27. Zou, L, Zhang, X, and Xiang, H. Malignant mixed epithelial and stromal tumor of the kidney: the second male case and review of literature. Int J Clin Exp Pathol. (2014) 7:2658–63.

PubMed Abstract | Google Scholar

28. Mudaliar, KM, Mehta, V, Gupta, GN, and Picken, MM. Expanding the morphologic spectrum of adult biphasic renal tumors – mixed epithelial and stromal tumor of the kidney with focal papillary renal cell carcinoma: case report and review of the literature. Int J Surg Pathol. (2014) 22:266–71. doi: 10.1177/1066896913488823,

PubMed Abstract | Crossref Full Text | Google Scholar

29. Vanecek, T, Pivovarcikova, K, Pitra, T, Peckova, K, Rotterova, P, Daum, O, et al. Mixed epithelial and stromal tumor of the kidney: mutation analysis of the DICER1 gene in 29 cases. Appl Immunohistochem Mol Morphol. (2017) 25:117–21. doi: 10.1097/PAI.0000000000000262,

PubMed Abstract | Crossref Full Text | Google Scholar

30. Bakavičius, A, Barisienė, M, Snicorius, M, Valančienė, D, Dasevičius, D, Žalimas, A, et al. Malignant mixed epithelial and stromal tumour of the kidney: a case report and a literature review. Acta Med Litu. (2018) 25:31–7. doi: 10.6001/actamedica.v25i1.3701,

PubMed Abstract | Crossref Full Text | Google Scholar

31. Nakagawa, T, Kanai, Y, Fujimoto, H, Kitamura, H, Furukawa, H, Maeda, S, et al. Malignant mixed epithelial and stromal tumours of the kidney: a report of the first two cases with a fatal clinical outcome. Histopathology. (2004) 44:302–4. doi: 10.1111/j.1365-2559.2004.01782.x,

PubMed Abstract | Crossref Full Text | Google Scholar

32. Yap, YS, Coleman, M, and Olver, I. Aggressive mixed epithelial-stromal tumour of the kidney treated with chemotherapy and radiotherapy. Lancet Oncol. (2004) 5:747–9. doi: 10.1016/S1470-2045(04)01651-1,

PubMed Abstract | Crossref Full Text | Google Scholar

33. Ozluk, Y, Sari, SO, Guzel, NT, Firat, P, Akbulut, F, and Kilicaslan, I. Mixed epithelial and stromal tumor of the kidney with sarcomatous transformation metastatic to the lung: a case report. Anal Quant Cytopathol Histpathol. (2015) 37:199–205.

Google Scholar

34. Arriola, AGP, Taylor, BL, Ma, S, Malkowicz, SB, and Lal, P. Malignant mixed epithelial and stromal tumor of the kidney with two simultaneous renal carcinomas in a male patient: case report and review of the literature. Int J Surg Pathol. (2018) 26:56–63. doi: 10.1177/1066896917720032

Crossref Full Text | Google Scholar

35. Levin, NP, Damjanov, I, and Depillis, VJ. Mesoblastic nephroma in an adult patient: recurrence 21 years after removal of the primary lesion. Cancer. (1982) 49:573–7. doi: 10.1002/1097-0142(19820201)49:3<>3.0.CO;2-#,

PubMed Abstract | Crossref Full Text | Google Scholar

36. Kuroda, N, Sakaida, N, Kinoshita, H, Matsuda, T, Hes, O, Michal, M, et al. Carcinosarcoma arising in mixed epithelial and stromal tumor of the kidney. APMIS. (2008) 116:1013–5. doi: 10.1111/j.1600-0463.2008.01063.x,

PubMed Abstract | Crossref Full Text | Google Scholar

37. Muller, S, Oevermann, A, Wenker, C, Altermatt, HJ, and Robert, N. A mixed epithelial and stromal tumor of the kidney in a ringtail lemur (Lemur catta). Vet Pathol. (2007) 44:243–6. doi: 10.1354/vp.44-2-243,

PubMed Abstract | Crossref Full Text | Google Scholar

38. Yamaoka, M, Sato, Y, Masumoto, Y, Enomoto, M, and Mitsumori, K. Spontaneous renal mixed epithelial and stromal tumor (MEST) in a beagle. J Toxicol Pathol. (2008) 21:189–92. doi: 10.1293/tox.21.189

Crossref Full Text | Google Scholar

39. Takabatake, M, Takuwa, Y, Takuwa, N, Yasuno, H, Matsumoto, S, Shibutani, M, et al. A case report of a renal mixed epithelial and stromal tumor in a heterozygous S1P2 receptor deficient mouse. J Vet Med Sci. (2008) 70:483–5. doi: 10.1292/jvms.70.483,

PubMed Abstract | Crossref Full Text | Google Scholar

40. Caliò, A, Cheng, L, Martignoni, G, Zhang, S, Brunelli, M, and Eble, JN. Mixed epithelial and stromal tumours of the kidney with malignant transformation: a clinicopathological study of four cases. Pathology. (2022) 54:707–20. doi: 10.1016/j.pathol.2022.03.011,

PubMed Abstract | Crossref Full Text | Google Scholar

41. Picken, MM, Bova, D, Pins, MR, and Quek, ML. Mixed epithelial and stromal tumor of the kidney with extension into inferior vena cava: case report and discussion of adult biphasic cystic renal lesions and the significance of vascular involvement. Case Rep Pathol. (2018) 2018:1–6. doi: 10.1155/2018/8234295,

PubMed Abstract | Crossref Full Text | Google Scholar

42. Mohanty, SK, and Parwani, AV. Mixed epithelial and stromal tumors of the kidney: an overview. Arch Pathol Lab Med. (2009) 133:1483–6. doi: 10.5858/133.9.1483,

PubMed Abstract | Crossref Full Text | Google Scholar

43. Adsay, NV, Eble, JN, Srigley, JR, Jones, EC, and Grignon, DJ. Mixed epithelial and stromal tumor of the kidney. Am J Surg Pathol. (2000) 24:958–70. doi: 10.1097/00000478-200007000-00007,

PubMed Abstract | Crossref Full Text | Google Scholar

44. Lane, BR, Campbell, SC, Remer, EM, Fergany, AF, Williams, SB, Novick, AC, et al. Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics. Urology. (2008) 71:1142–8. doi: 10.1016/j.urology.2007.11.106,

PubMed Abstract | Crossref Full Text | Google Scholar

45. Jithesh, M, Bhat, S, Paul, F, and Jose, A. An unusual presentation of mixed epithelial and stromal tumor of the kidney. Kerala Med J. (2016) 9:76–8.

Google Scholar

46. Gokden, N, Dawson, K, and Lindberg, M. Malignant rhabdoid tumor arising in a mixed epithelial, stromal tumor of kidney: report of a male case, review of the literature. Pathol Res Pract. (2020) 216:3151. doi: 10.1016/j.prp.2020.153151,

PubMed Abstract | Crossref Full Text | Google Scholar

47. Williamson, SR, and Calio, A. Tumours of the kidney. Mixed epithelial and stromal renal tumours In: SR Williamson, editor. WHO classification of Tumours editorial board: urinary and male genital tumours. Lyon: International Agency for Research on Cancer (2022)

Google Scholar

48. Farias, JA, Laryea, J, Gokden, N, and Kamel, MH. Peritoneal seeding following incomplete resection of mixed epithelial stromal tumor of the kidney: first case report. Urol Ann. (2016) 8:114–7. doi: 10.4103/0974-7796.171493,

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: tiger, kidney, tumor, mixed epithelial and stromal tumor, pathology

Citation: Švara T, Gombač M, Kojc N, Harej M, Kastelic M, Kržan P, Dolenšek T and Kvapil P (2025) Case Report: Clinical and pathological features of a metastasizing malignant mixed epithelial and stromal tumor of the kidney in a Siberian tiger (Panthera tigris altaica). Front. Vet. Sci. 12:1656594. doi: 10.3389/fvets.2025.1656594

Received: 30 June 2025; Accepted: 21 October 2025;
Published: 09 December 2025.

Edited by:

Francisco Javier Salguero, UK Health Security Agency (UKHSA), United Kingdom

Reviewed by:

José Manuel Verdes, Universidad de la República, Uruguay
Alejandro Suarez-Bonnet, Royal Veterinary College (RVC), United Kingdom
Dylan Yaffy, Royal Veterinary College (RVC), United Kingdom

Copyright © 2025 Švara, Gombač, Kojc, Harej, Kastelic, Kržan, Dolenšek and Kvapil. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tanja Švara, dGFuamEuc3ZhcmFAdmYudW5pLWxqLnNp

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.